<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00537446</url>
  </required_header>
  <id_info>
    <org_study_id>AAAC7394</org_study_id>
    <nct_id>NCT00537446</nct_id>
  </id_info>
  <brief_title>Effect of Noninvasive Ventilation on Lung Function in Amyotrophic Lateral Sclerosis</brief_title>
  <official_title>Effect of Noninvasive Positive Pressure Ventilation on Pulmonary Function Testing in Amyotrophic Lateral Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Amyotrophic Lateral Sclerosis (ALS), or &quot;Lou Gehrig's Disease&quot;, is a fatal disorder that&#xD;
      causes progressive degeneration and weakening of the muscles of breathing, leading to&#xD;
      breathing insufficiency and eventually breathing failure. This breathing insufficiency is&#xD;
      commonly treated with a breathing assistance device, known as noninvasive positive pressure&#xD;
      ventilation (NIPPV). While generally well tolerated and accepted, it is not clear whether or&#xD;
      to what extent NIPPV in fact helps breathing function: some data suggest that NIPPV preserves&#xD;
      breathing function over time, whereas other data suggest that it actually causes breathing&#xD;
      function to decline more quickly. No studies have shown what the acute effect of NIPPV is on&#xD;
      breathing muscle function in ALS patients.&#xD;
&#xD;
      This study will test the hypothesis that the acute use of NIPPV, at pressure levels that are&#xD;
      in common clinical use, will cause measurable changes in tests of breathing function,&#xD;
      compared to baseline and to lower levels of NIPPV. We expect that the results of this study&#xD;
      will help to clarify whether and to what extent NIPPV assists respiratory muscle function in&#xD;
      patients with ALS.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient enrollment&#xD;
  </why_stopped>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in Pulmonary Function and Respiratory Muscle Pressure Testing</measure>
    <time_frame>5 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in Gas Exchange</measure>
    <time_frame>5 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in Subjective Dyspnea Between Baseline and the Two Different Ventilator Modes</measure>
    <time_frame>5 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <condition>Motor Neuron Disease</condition>
  <arm_group>
    <arm_group_label>High-level ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each subject will spend 2 hours receiving high-level noninvasive ventilation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-level ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each subject will receive 2 hours of low-level noninvasive positive pressure ventilation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>noninvasive positive pressure ventilation</intervention_name>
    <description>Each subject will undergo 2 hours of high-level noninvasive positive pressure ventilation, with an inspiratory positive airway pressure of 12 cm H2O and an expiratory positive airway pressure of 3 cm H2O.</description>
    <arm_group_label>High-level ventilation</arm_group_label>
    <other_name>&quot;BiPAP&quot; (Respironics), variable positive airway pressure (VPAP) (ResMed), bilevel positive airway pressure, noninvasive ventilation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>noninvasive positive pressure ventilation</intervention_name>
    <description>Each subject will undergo 2 hours of low-level noninvasive positive pressure ventilation, with an inspiratory positive airway pressure of 6 cm H2O and an expiratory positive airway pressure of 3 cm H2O.</description>
    <arm_group_label>Low-level ventilation</arm_group_label>
    <other_name>BiPAP (Respironics), VPAP (ResMed), bilevel positive airway pressure, noninvasive ventilation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  clinical diagnosis of amyotrophic lateral sclerosis&#xD;
&#xD;
          -  clinical indication to start noninvasive ventilation (forced vital capacity &lt; 50%&#xD;
             predicted or signs/symptoms of respiratory insufficiency)&#xD;
&#xD;
          -  age 18 to 80 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  prior institution of NIPPV&#xD;
&#xD;
          -  inability to safely use NIPPV&#xD;
&#xD;
          -  indications for tracheostomy assisted ventilation because of inability to clear&#xD;
             secretions from the airway&#xD;
&#xD;
          -  inability or unwillingness to perform pulmonary function testing&#xD;
&#xD;
          -  presence of advanced dementia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert C Basner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eleanor and Lou Gehrig ALS/MDA Center at Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 27, 2007</study_first_submitted>
  <study_first_submitted_qc>September 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2007</study_first_posted>
  <results_first_submitted>September 16, 2020</results_first_submitted>
  <results_first_submitted_qc>November 5, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 27, 2020</results_first_posted>
  <last_update_submitted>November 5, 2020</last_update_submitted>
  <last_update_submitted_qc>November 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Robert C. Basner</investigator_full_name>
    <investigator_title>Special Lecturer in Medicine</investigator_title>
  </responsible_party>
  <keyword>noninvasive ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>High Level and Low Level Ventilation</title>
          <description>All participants are listed as one group, as the breakdown per Arm/Group is not available (PI no longer has raw data on file).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>High Level and Low Level Ventilation</title>
          <description>All participants</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Difference in Pulmonary Function and Respiratory Muscle Pressure Testing</title>
        <time_frame>5 hours</time_frame>
        <population>Data were collected but not analyzed as specified in the title because the sample size does not generate enough statistical significance. PI no longer has raw data on file. All efforts have been made to retrieve the data and data could not be recovered.</population>
        <group_list>
          <group group_id="O1">
            <title>High-level Ventilation</title>
            <description>Each subject will spend 2 hours receiving high-level noninvasive ventilation.&#xD;
noninvasive positive pressure ventilation: Each subject will undergo 2 hours of high-level noninvasive positive pressure ventilation, with an inspiratory positive airway pressure of 12 cm H2O and an expiratory positive airway pressure of 3 cm H2O.</description>
          </group>
          <group group_id="O2">
            <title>Low-level Ventilation</title>
            <description>Each subject will receive 2 hours of low-level noninvasive positive pressure ventilation.&#xD;
noninvasive positive pressure ventilation: Each subject will undergo 2 hours of low-level noninvasive positive pressure ventilation, with an inspiratory positive airway pressure of 6 cm H2O and an expiratory positive airway pressure of 3 cm H2O.</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Pulmonary Function and Respiratory Muscle Pressure Testing</title>
          <population>Data were collected but not analyzed as specified in the title because the sample size does not generate enough statistical significance. PI no longer has raw data on file. All efforts have been made to retrieve the data and data could not be recovered.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Difference in Gas Exchange</title>
        <time_frame>5 hours</time_frame>
        <population>Data were collected but not analyzed as specified in the title because the sample size does not generate enough statistical significance. PI no longer has raw data on file. All efforts have been made to retrieve the data and data could not be recovered.</population>
        <group_list>
          <group group_id="O1">
            <title>High-level Ventilation</title>
            <description>Each subject will spend 2 hours receiving high-level noninvasive ventilation.&#xD;
noninvasive positive pressure ventilation: Each subject will undergo 2 hours of high-level noninvasive positive pressure ventilation, with an inspiratory positive airway pressure of 12 cm H2O and an expiratory positive airway pressure of 3 cm H2O.</description>
          </group>
          <group group_id="O2">
            <title>Low-level Ventilation</title>
            <description>Each subject will receive 2 hours of low-level noninvasive positive pressure ventilation.&#xD;
noninvasive positive pressure ventilation: Each subject will undergo 2 hours of low-level noninvasive positive pressure ventilation, with an inspiratory positive airway pressure of 6 cm H2O and an expiratory positive airway pressure of 3 cm H2O.</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Gas Exchange</title>
          <population>Data were collected but not analyzed as specified in the title because the sample size does not generate enough statistical significance. PI no longer has raw data on file. All efforts have been made to retrieve the data and data could not be recovered.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Difference in Subjective Dyspnea Between Baseline and the Two Different Ventilator Modes</title>
        <time_frame>5 hours</time_frame>
        <population>Data were collected but not analyzed as specified in the title because the sample size does not generate enough statistical significance. PI no longer has raw data on file. All efforts have been made to retrieve the data and data could not be recovered.</population>
        <group_list>
          <group group_id="O1">
            <title>High-level Ventilation</title>
            <description>Each subject will spend 2 hours receiving high-level noninvasive ventilation.&#xD;
noninvasive positive pressure ventilation: Each subject will undergo 2 hours of high-level noninvasive positive pressure ventilation, with an inspiratory positive airway pressure of 12 cm H2O and an expiratory positive airway pressure of 3 cm H2O.</description>
          </group>
          <group group_id="O2">
            <title>Low-level Ventilation</title>
            <description>Each subject will receive 2 hours of low-level noninvasive positive pressure ventilation.&#xD;
noninvasive positive pressure ventilation: Each subject will undergo 2 hours of low-level noninvasive positive pressure ventilation, with an inspiratory positive airway pressure of 6 cm H2O and an expiratory positive airway pressure of 3 cm H2O.</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Subjective Dyspnea Between Baseline and the Two Different Ventilator Modes</title>
          <population>Data were collected but not analyzed as specified in the title because the sample size does not generate enough statistical significance. PI no longer has raw data on file. All efforts have been made to retrieve the data and data could not be recovered.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>5 hours</time_frame>
      <desc>No adverse events were observed.</desc>
      <group_list>
        <group group_id="E1">
          <title>High-level Ventilation</title>
          <description>Each subject will spend 2 hours receiving high-level noninvasive ventilation.&#xD;
noninvasive positive pressure ventilation: Each subject will undergo 2 hours of high-level noninvasive positive pressure ventilation, with an inspiratory positive airway pressure of 12 cm H2O and an expiratory positive airway pressure of 3 cm H2O.</description>
        </group>
        <group group_id="E2">
          <title>Low-level Ventilation</title>
          <description>Each subject will receive 2 hours of low-level noninvasive positive pressure ventilation.&#xD;
noninvasive positive pressure ventilation: Each subject will undergo 2 hours of low-level noninvasive positive pressure ventilation, with an inspiratory positive airway pressure of 6 cm H2O and an expiratory positive airway pressure of 3 cm H2O.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Robert Basner, MD</name_or_title>
      <organization>Columbia University Irving Medical Center</organization>
      <email>rcb42@cumc.columbia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

